Acknowledgements
No public or private funding was used in this study. We thank Ms. Junko
Yokobori, Ms. Mika Ohki, and Ms. Yumi Kobayashi for their exceptional
support of this study as clinical research coordinators. Ms. Eriko
Takamine, a certified genetic counselor, helped to organize the
Molecular Tumor Board and the genetic counseling of patients who had
potential germline mutations. We would like to extend our gratitude to
Ms. Tomomi Urata, Ms. Rieko Furuya, and Ms. Akiko Noguchi for their
administrative support. Finally, we thank H. Nikki March, PhD, from
Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.